Due to the impending storm and weather conditions, the Tisch MS Research Center of New York will be closed on Tuesday, January 27th.
Tisch MS News
The Tisch MS Research Center will be closed Monday, January 19th in observance of Dr. Martin Luther King, Jr. Day.
Dr. Massimiliano Cristofanilli and Dr. Fozia Mir presented at the 2014 Society for Neuroscience Meeting in Washington D.C. on November 15th. They spoke to an eager audience of over 200 scientists as part of the Demyelinating Disorders Nanosymposium. The annual meeting of the Society for Neuroscience is the world’s largest event focused on scientific discovery related to the brain and nervous system.
On November 6, Neurology Today Online featured Tisch MSRCNY in a review of news coming out of the ACTRIMS/ECTRIMS Annual Meeting in September examining the safety of stem cell therapy in MS treatment. The article discussed two different trials that were found to be safe and well tolerated in multiple sclerosis patients: one using intravenous injection of mesenchymal stem cells and the other Tisch MSRCNY’s protocol using intrathecal injections of mesenchymal stem cells.
Thank you to all who attended the 17th Annual Tisch MS Research Patient Symposium. In response to your requests, a review of the material presented will be posted on this website and appear in the next issue of our newsletter, Healing MS.
Dr. Violaine Harris and Dr. Saud A. Sadiq co-authored a review entitled “Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status and this has been accepted for publication in the Journal Molecular Diagnosis and Therapy.
The journal Neurology® Neuroimmunology and Neuroinflammation accepted a paper by lead author Dr. Fozia Mir entitled, “Cerebrospinal fluid isoprostane levels are a biomarker of oxidative stress in multiple sclerosis.” The paper is authored by Dr. Mir, Donald Lee, Hetal Ray, and Saud A. Sadiq, MD and in it the team has identified a lipid, 8-iso-prostaglandinF2α (8-iso-PGF2α), as a biomarker for disease activity and oxidative stress in the cerebrospinal fluid (CSF) of multiple sclerosis patients.
Last week your Tisch MSRCNY researchers presented six abstracts, including five posters, at the Joint ACTRIMS-ECTRIMS Meeting (Americas and European Committees for Treatment and Research in Multiple Sclerosis) in Boston. This was the sixth triennial event dedicated to advancing the understanding of MS and attracted over 9,000 delegates including more than one hundred exhibitors.
Tisch MS Research Center of New York is proud to be featured in the September 2014 issue of “Neurology Today.” The article “Myelinating Oligodendrocytes Derived from Primary Progressive MS Patients: Scientists Developed Faster, More Efficient Methodology,” discusses research focusing on an accelerated protocol to induce stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system.
Your Tisch MS Researchers head to Boston today to present their work at the 2014 Joint ACTRIMS-ECTRIMS Meeting!
Pages
